Clinical Trials List
2018-03-16 - 2024-12-05
Phase III
Terminated5
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- RUEY-LONG HONG Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
- HUAI-CHENG HUANG 無
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Co-Principal Investigator
- Mu-Hsin Chang Division of Hematology & Oncology
- 陳盛裕 未分科
- Sheng-Yu Chen Division of Hematology & Oncology
- Muh-Hwa Yang Division of Hematology & Oncology
- Tsung-Lun Lee Division of Otolaryngology
- 朱本元 Division of Otolaryngology
- 戴世光 Division of Otolaryngology
The Actual Total Number of Participants Enrolled
2 Terminated
Audit
None
Co-Principal Investigator
- Shang-Yin Wu Division of General Surgery
- 劉奕廷 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Co-Principal Investigator
- Ming-Yu Lien Division of Hematology & Oncology
- Tzu-Ting Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
26 participants
-
Global
406 participants
